| HHS Public Access R Bazak, M Houri, S El Achy, S Kamel, T Refaat J Cancer Res Clin Oncol 141 (5), 769-784, 2015 | 794* | 2015 |
| Passive targeting of nanoparticles to cancer: A comprehensive review of the literature R Bazak, M Houri, S El Achy, W Hussein, T Refaat Molecular and clinical oncology 2 (6), 904-908, 2014 | 393 | 2014 |
| Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer T Refaat, S Sachdev, V Sathiaseelan, I Helenowski, S Abdelmoneim, ... The Breast 24 (4), 418-425, 2015 | 47 | 2015 |
| Thyroid V50 highly predictive of hypothyroidism in head-and-neck cancer patients treated with intensity-modulated radiotherapy (IMRT) S Sachdev, T Refaat, ID Bacchus, V Sathiaseelan, BB Mittal American Journal of Clinical Oncology 40 (4), 413-417, 2017 | 44 | 2017 |
| Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients S Sachdev, T Refaat, ID Bacchus, V Sathiaseelan, BB Mittal Radiation Oncology 10, 1-8, 2015 | 42 | 2015 |
| Markov model and cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer T Refaat, M Choi, G Gaber, K Kiel, M Mehta, W Gradishar, W Small Jr American journal of clinical oncology 37 (5), 480-485, 2014 | 31 | 2014 |
| c-Met overexpression in cervical cancer, a prognostic factor and a potential molecular therapeutic target T Refaat, ED Donnelly, S Sachdev, V Parimi, S El Achy, P Dalal, M Farouk, ... American journal of clinical oncology 40 (6), 590-597, 2017 | 25 | 2017 |
| Evaluation of outcomes in patients with carcinoma of the cervix treated with concurrent radiation and cisplatin versus cisplatin/5-FU compared with radiation alone ED Donnelly, T Refaat, M Gentile, A Herskovic, J Boyle, I Helenowski, ... American journal of clinical oncology 38 (5), 437-441, 2015 | 24 | 2015 |
| Development of a standardized method for contouring the larynx and its substructures M Choi, T Refaat, MS Lester, I Bacchus, AW Rademaker, BB Mittal Radiation Oncology 9, 1-7, 2014 | 23 | 2014 |
| Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapy TO Thomas, T Refaat, M Choi, I Bacchus, S Sachdev, AW Rademaker, ... Radiation Oncology 10, 1-8, 2015 | 19 | 2015 |
| Gamma Knife stereotactic radiosurgery for grade 2 meningiomas T Refaat, M Gentile, S Sachdev, P Dalal, A Butala, S Gutiontov, ... Journal of Neurological Surgery Part B: Skull Base 78 (04), 288-294, 2017 | 16 | 2017 |
| Impact of p53, HIF1a, ki-67, CA-9, and GLUT1 expression on treatment outcomes in locally advanced cervical cancer patients treated with definitive chemoradiation therapy G Gaber, S El Achy, GA Khedr, V Parimi, I Helenowksi, ED Donnelly, ... American Journal of Clinical Oncology 44 (2), 58-67, 2021 | 14 | 2021 |
| Concomitant chemoradiotherapy with image-guided pulsed dose rate brachytherapy as a definitive treatment modality for early-stage cervical cancer T Refaat, B Castelain, W Small Jr, A Elsaid, N Lotfy, E Lartigau, P Nickers American journal of clinical oncology 38 (3), 289-293, 2015 | 13 | 2015 |
| Dose-volume relationship for laryngeal substructures and aspiration in patients with locally advanced head-and-neck cancer KG Petras, AW Rademaker, T Refaat, M Choi, TO Thomas, BR Pauloski, ... Radiation Oncology 14, 1-7, 2019 | 12 | 2019 |
| Whole-Field Sequential Intensity–Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma T Refaat, M Choi, TO Thomas, I Bacchus, M Agulnik, HJ Pelzer, AL Mellott, ... American journal of clinical oncology 38 (6), 588-594, 2015 | 11 | 2015 |
| Volume-based pulsed-dose-rate brachytherapy boosting concurrent chemoradiation as a definitive treatment modality in cervical cancer T Refaat, P Nickers, E Lartigau Brachytherapy 13 (1), 80-87, 2014 | 11 | 2014 |
| Distribution of iron oxide core-titanium dioxide shell nanoparticles in VX2 tumor bearing rabbits introduced by two different delivery modalities T Refaat, D West, S El Achy, V Parimi, J May, L Xin, KR Harris, W Liu, ... Nanomaterials 6 (8), 143, 2016 | 10 | 2016 |
| c-Met Overexpression in Cervical Cancer: A Prognostic Factor and a Potential Molecular Therapeutic Target T Refaat, ED Donnelly, S Sachdev, V Parimi, S El Achy, P Dalal, M Farouk, ... International Journal of Radiation Oncology, Biology, Physics 93 (3), E252, 2015 | 10 | 2015 |
| Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States–understanding the transition to adaptive, ultra-hypofractionated … MD Chuong, MA Clark, LE Henke, AU Kishan, L Portelance, PJ Parikh, ... Clinical and translational radiation oncology 38, 161-168, 2023 | 9 | 2023 |
| Low-dose-rate brachytherapy boosting concurrent chemoradiation as a definitive treatment modality for cervical cancer: long-term clinical results of outcomes and associated … T Refaat, ED Donnelly, M Gentile, C Novak, Y Yuan, GA Khedr, ... American journal of clinical oncology 39 (2), 196-203, 2016 | 9 | 2016 |
Sean SachdevAssociate Professor, Northwestern University在 northwestern.edu 的电子邮件经过验证
